Tarsus Pharmaceuticals, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
TARS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
15440 Laguna Canyon Road, Irvine, CA

Insiders trading volume in the past year

Tarsus Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vivo Capital IX, LLC 10%+ Owner $49.4M May 5, 2022
Rtw Investments, Lp 10%+ Owner $40.3M May 7, 2021
Bobak R. Azamian President/CEO and Board Chair, Director $27.8M -$480K -1.7% Mar 15, 2024
Jeffrey Farrow Chief Financial Officer and Chief Strategy Officer $4.85M -$287K -5.58% Jun 17, 2024
William J. Link Phd Director $4.77M -$913K -16.1% Aug 12, 2024
Seshadri Neervannan Chief Operating Officer $2.48M -$149K -5.69% Mar 15, 2024
Aziz Mottiwala Chief Commercial Officer $2.4M -$146K -5.72% Mar 15, 2024
Bryan Wahl General Counsel $1.92M -$136K -6.61% Mar 15, 2024
Elizabeth Yeu Lin Chief Medical Officer $1.75M Nov 4, 2024
Dianne C. Whitfield Chief Human Resources Officer $1.71M -$132K -7.16% Mar 15, 2024
Leonard M. Greenstein Chief Financial Officer $536K Apr 20, 2023
Wendy L. Yarno Director $339K Jun 24, 2024
Michael Ackermann Director $273K Jun 16, 2022
Andrew D. Goldberg Director $229K Jun 24, 2024
Rosemary A. Crane Director $202K Jun 24, 2024
Bhaskar Chaudhuri Director $202K Jun 24, 2024
Scott W. Morrison Director $195K Sep 30, 2024
Mark J. Holdbrook V.P., Clinical Affairs $194K Mar 17, 2023
Katherine Goodrich Director $178K Nov 13, 2024
Jason E. Tester Director, 10%+ Owner $110K Jun 15, 2021
Jose M. Trevejo Chief Medical Officer $45K Dec 20, 2023

Recent Insider Transactions by Companies or Individuals for Tarsus Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.